StreetAlpha.app
Home › Stocks › YARW

Yarrow Bioscience, Inc. (YARW)

$14.03
▲ +0.68%
LAST CLOSE · NOV 17

Yarrow Bioscience is a New Haven biopharmaceutical company developing drugs for inflammatory and immune conditions. It last closed at $14.03 on Nov 17, up 0.68% on the day. The average 12-month price target from 2 analysts is $50.00 (+256.5% from the last close), with a high of $60.00 and a low of $40.00.

AI Auto Pilots
Is YARW in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$482K
+1.3% vs a year ago
Net income
−$18.7M
−3881.5% margin
Operating margin
−4134.6%
−$19.9M operating income
Valuation
Market cap
$37.4M
2.7M shares
P/E
–
Price to sales
77.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.9M
At Jun 30
Debt
$0
At Jun 30
Shareholder equity
$22.1M
Shares outstanding
2.7M
At Aug 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $931K$931KFY2021FY2022: $477K$477KFY2022FY2023: $424K$424KFY2023FY2024: $501K$501KFY2024FY2025: $570K$570KFY2025

From YARW's SEC filings, latest 10-Q for the period ending Jun 30, 2026 (filed Aug 13). Last 12 months adds up the four latest quarters.

Last report
Nov 12
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated YARW in the past 90 days, not enough for a consensus
Average 12-month target
$50.00
▲ 256.5% upside

Based on 2 analysts who set a price target on YARW in the past 90 days. The average target is $50.00, with a high of $60.00 and a low of $40.00, compared with the last close of $14.03.

Low $40.00Avg $50.00High $60.00
Blue marker: last close $14.03
Highest target$60.00
Average target$50.00
Lowest target$40.00
Latest rating changes
JefferiesInitiated
Nov 16Buy$40
GuggenheimInitiated
Nov 6Buy$60
BTIGInitiated
Aug 3Buy$58
DateFirmActionRatingPrice target
Nov 16JefferiesInitiatedBuy$40
Nov 6GuggenheimInitiatedBuy$60
Aug 3BTIGInitiatedBuy$58
Loading…

Technical Analysis

YARW · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 26% below its 20 day and 52% below its 50 day average. It is 114% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 37), near oversold. The nearest support is the Pivot S1 at $13.40, and the nearest resistance the Pivot at $14.15.

Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 17.6%/day
Key levels
$46.9552 week high+234.6%
$30.03200 day average+114.0%
$28.79100 day average+105.2%
$21.2550 day average+51.5%
$19.92Swing high (Nov 12)+42.0%
$17.7120 day average+26.2%
$14.77Pivot R1+5.3%
$14.15Pivot+0.9%
$14.03Last close
$13.40Pivot S1−4.5%
$12.3852 week low−11.8%
$12.38Swing low (Nov 5)−11.8%
Indicators
RSI (14)36.67Weak, oversold below 30Neutral
MACD-1.70Above its signal lineBullish
Stochastic35.6Middle of its rangeNeutral
ADX (14)39.7Trending down
Williams %R-80.2Oversold below −80, overbought above −20Oversold
CCI (20)-137.0Oversold below −100, overbought above 100Oversold
Rate of change−23.6%Change over 10 sessionsBearish
ATR (14)$2.47Typical daily range, 17.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for YARW

What happened before

See how YARW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow YARW usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How YARW has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in YARW in the last 90 days.

Loading…

See today’s whale options flow across the market →

YARW Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲48 buying vs 0 selling
  • ●Shares held by funds +0.0%
  • ●Funds holding +49
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q3 2026This quarterLast quarterChange
Funds holding49––
In funds' top 101––
Held by funds–––
New / increased48 / 0––
Reduced / sold out0 / 0––
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See YARW institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether YARW is in one of them and how their past YARW trades turned out.

YARW in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered YARW in an article yet. Here's the latest on the wider market.

About Yarrow Bioscience

Yarrow Bioscience is a biopharmaceutical company based in New Haven, Connecticut, that develops treatments for inflammatory and immune conditions. Its work centers on BET inhibitors, a class of small molecule drugs that aim to calm overactive inflammatory signaling in the body. Its candidates are still in clinical testing and have not been approved for sale. The company's planned focus is on Graves disease and Thyroid Eye Disease, with patients and their treating doctors as the intended users of any approved treatment.

Headquarters
New Haven, CT